The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIVAX SA | SPONSORED ADS | 00370M103 | 30,459,000 | 2,130,000 | SH | DFND | 1 | 2,130,000 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 31,633,868 | 1,069,796 | SH | DFND | 1 | 1,069,796 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 107,028,000 | 2,700,000 | SH | DFND | 1 | 2,700,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 35,034,181 | 3,142,079 | SH | DFND | 1 | 3,142,079 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 23,512,000 | 400,000 | SH | DFND | 1 | 400,000 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 123,799,000 | 1,780,000 | SH | DFND | 1 | 1,780,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 21,058,750 | 2,125,000 | SH | DFND | 1 | 2,125,000 | 0 | 0 | ||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | 9,197,900 | 515,000 | SH | DFND | 1 | 515,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 18,297,500 | 1,300,000 | SH | DFND | 1 | 1,300,000 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 42,214,335 | 6,616,667 | SH | DFND | 1 | 6,616,667 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 9,912,000 | 300,000 | SH | Put | DFND | 1 | 300,000 | 0 | 0 | |
BIOATLA INC | COM | 09077B104 | 4,027,793 | 1,170,870 | SH | DFND | 1 | 1,170,870 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 33,741,706 | 616,963 | SH | DFND | 1 | 616,963 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 53,384,536 | 3,570,872 | SH | DFND | 1 | 3,570,872 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 99,037,657 | 3,203,029 | SH | DFND | 1 | 3,203,029 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 18,766,000 | 1,100,000 | SH | DFND | 1 | 1,100,000 | 0 | 0 | ||
CARGO THERAPEUTICS INC | COM | 14179K101 | 26,394,806 | 1,182,563 | SH | DFND | 1 | 1,182,563 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 6,346,080 | 561,600 | SH | DFND | 1 | 561,600 | 0 | 0 | ||
CG ONCOLOGY INC | COM | 156944100 | 35,120,000 | 800,000 | SH | DFND | 1 | 800,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 11,009,394 | 5,560,300 | SH | DFND | 1 | 5,560,300 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 79,461,000 | 2,025,000 | SH | DFND | 1 | 2,025,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 53,831,500 | 1,150,000 | SH | DFND | 1 | 1,150,000 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 7,782,500 | 125,000 | SH | DFND | 1 | 125,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 54,839,180 | 3,006,534 | SH | DFND | 1 | 3,006,534 | 0 | 0 | ||
ENGENE HOLDINGS INC | COM | 29286M105 | 16,950,000 | 1,000,000 | SH | DFND | 1 | 1,000,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 142,483,167 | 6,893,235 | SH | DFND | 1 | 6,893,235 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 6,321,838 | 593,043 | SH | DFND | 1 | 593,043 | 0 | 0 | ||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 30,253,600 | 2,909,000 | SH | DFND | 1 | 2,909,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 19,746,000 | 450,000 | SH | DFND | 1 | 450,000 | 0 | 0 | ||
IMMUNEERING CORP | CLASS A COM | 45254E107 | 9,523,339 | 3,295,273 | SH | DFND | 1 | 3,295,273 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 15,599,750 | 575,000 | SH | DFND | 1 | 575,000 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 28,237,500 | 750,000 | SH | DFND | 1 | 750,000 | 0 | 0 | ||
KORRO BIO INC | COM | 500946108 | 47,625,300 | 529,170 | SH | DFND | 1 | 529,170 | 0 | 0 | ||
KYVERNA THERAPEUTICS INC | COM | 501976104 | 10,929,600 | 440,000 | SH | DFND | 1 | 440,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 4,668,000 | 75,000 | SH | DFND | 1 | 75,000 | 0 | 0 | ||
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 72,427,846 | 3,353,141 | SH | DFND | 1 | 3,353,141 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 29,380,000 | 3,250,000 | SH | DFND | 1 | 3,250,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 11,648,000 | 2,600,000 | SH | DFND | 1 | 2,600,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 32,196,450 | 715,000 | SH | DFND | 1 | 715,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 426,661,205 | 8,494,151 | SH | DFND | 1 | 8,494,151 | 0 | 0 | ||
NEUROGENE INC | COM | 64135M105 | 27,420,543 | 538,714 | SH | DFND | 1 | 538,714 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 35,475,000 | 1,500,000 | SH | DFND | 1 | 1,500,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 14,593,500 | 1,350,000 | SH | DFND | 1 | 1,350,000 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 39,551,841 | 1,711,460 | SH | DFND | 1 | 1,711,460 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 79,936,200 | 1,310,000 | SH | DFND | 1 | 1,310,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 4,460,815 | 496,750 | SH | DFND | 1 | 496,750 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 23,831,500 | 550,000 | SH | DFND | 1 | 550,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 8,082,000 | 300,000 | SH | DFND | 1 | 300,000 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 13,500,000 | 625,000 | SH | DFND | 1 | 625,000 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 9,482,500 | 250,000 | SH | DFND | 1 | 250,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 5,766,701 | 427,163 | SH | DFND | 1 | 427,163 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 77,756,358 | 2,139,102 | SH | DFND | 1 | 2,139,102 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 28,625,000 | 1,250,000 | SH | DFND | 1 | 1,250,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 46,792,350 | 685,000 | SH | DFND | 1 | 685,000 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 14,905,000 | 2,710,000 | SH | DFND | 1 | 2,710,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 4,648,000 | 350,000 | SH | DFND | 1 | 350,000 | 0 | 0 | ||
VYNE THERAPEUTICS INC | COM | 92941V308 | 4,280,612 | 1,394,336 | SH | DFND | 1 | 1,394,336 | 0 | 0 |